UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,867 shares of the healthcare conglomerate's stock after buying an additional 13,505 shares during the quarter. UnitedHealth Group makes up 0.6% of Quantinno Capital Management LP's portfolio, making the stock its 19th biggest holding. Quantinno Capital Management LP's holdings in UnitedHealth Group were worth $57,601,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in UNH. Signal Advisors Wealth LLC grew its holdings in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares in the last quarter. Waycross Partners LLC lifted its stake in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Full Sail Capital LLC grew its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Lmcg Investments LLC boosted its stake in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after buying an additional 4,022 shares during the last quarter. Finally, Soros Fund Management LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $39,413,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Up 6.2%

NYSE:UNH traded up $16.89 during mid-day trading on Friday, reaching $291.24. The company's stock had a trading volume of 70,463,502 shares, compared to its average volume of 5,875,758. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $264.20 billion, a PE ratio of 18.79, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The stock has a fifty day moving average of $470.82 and a 200-day moving average of $513.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company earned $6.91 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $560.00 to $350.00 in a research report on Wednesday. KeyCorp reduced their price objective on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research note on Wednesday. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Six investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $486.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.